EGFR and neoplasm: EGFR expression was then evaluated by immunohistochemistry (IHC) in primary tumor tissues and the corresponding brain metastasis lesions from two cases of patients diagnosed with metastatic breast cancer, after confirming the existence of tumor cells by hematoxylin and eosin (HE) staining (Figure 1B, top two rows).